Ivan Peyron/ISTH
Sep 15, 2025, 17:40
Ivan Peyron Encourages You to Support Resaerch Targeting Rare Coagulation Diseases and Platelet Pathologies
Ivan Peyron, Research Engineer at INSERM, shared on LinkedIn:
Support research!
Bleeding disorders and clotting problems are responsible for many serious illnesses and strokes.
Our mission in the laboratory:
- Deciphering the mechanisms of coagulation
- Understanding diseases like von Willebrand disease and hemophilia
- Improving diagnosis and treatment for patients
Thanks to our innovative nanobody platform (mini-antibodies) developed since 2014, we create:
- Unique tools for research
- Promising therapeutic candidates
Our current projects target rare coagulation diseases and platelet pathologies, to transform patients’ lives.
- By making a donation, you are directly contributing to:
- Better Stroke Prevention
- Improving the management of cardiovascular and inflammatory diseases
- Bringing hope to thousands of patients around the world
Support our research and help us make a difference!”
To support the research, follow the link.
Stay updated on the latest news in the field of clotting disorders with Hemostasis Today.
-
Sep 24, 2026, 06:52Gina Sado: Screening-Detected Atrial Fibrillation Carries High Risk of Heart Failure
-
Sep 24, 2026, 06:33Benjamin Vipler: Optimal Oral Anticoagulation Choice in Atrial Fibrillation and Advanced CKD
-
Sep 24, 2026, 06:08Christopher Salerno: AI-Powered At-Home Anemia Screening Advances Telehealth Access
-
Sep 24, 2026, 05:38Aya Qattan: When a Normal CBC Does Not Mean Normal Iron Status
-
Sep 24, 2026, 05:11Mastering Warm Autoimmune Hemolytic Anemia Diagnosis and Practice – ASH Education
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency